PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression.

Peng J, Wang T, Yue C, Luo X, Xiao P

Open source

DOI
10.3389/fonc.2022.1004511
Published
2022
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2022.1004511,
  title = {PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression.},
  author = {Peng J and Wang T and Yue C and Luo X and Xiao P},
  year = {2022},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2022.1004511},
  url = {https://doi.org/10.3389/fonc.2022.1004511}
}

RIS

TY  - JOUR
TI  - PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression.
AU  - Peng J
AU  - Wang T
AU  - Yue C
AU  - Luo X
AU  - Xiao P
PY  - 2022
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2022.1004511
UR  - https://doi.org/10.3389/fonc.2022.1004511
ER  - 

APA

J, P., T, W., C, Y., X, L., & P, X. (2022). PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression.. Frontiers in oncology. https://doi.org/10.3389/fonc.2022.1004511

Source records